About

Our mission statement and timeline

Never let technology be a limiting factor for patient care

This is our mission statement. We will always strive to create the best technology possible.

RSNA 2022 NNL and nordicMEDiVA team photo

Brief timeline

  • 2024 - nordicMEDiVA FDA clearance for "task-based fMRI" and "Diffusion and Tractography" modules, and full product launch in the US

  • 2022 - nordicMEDiVA FDA clearance for "DSC Perfusion" module

  • 2021 - The first nordicMEDiVA module launched

  • 2019 - We spun out from NordicNeuroLab to focus on software development

  • 2008 - nordicBrainEx launched

  • 2005 - nordicICE launched